Variability in Urate-lowering Therapy Prescribing: A Gout, Hyperuricemia and Crystal-Associated Disease Network (G-CAN) Physician Survey
J Rheumatol
.
2021 Jan 1;48(1):152-153.
doi: 10.3899/jrheum.200347.
Epub 2020 Oct 1.
Authors
Lisa K Stamp
1
,
William Taylor
2
,
Angelo Gaffo
;
Gout and Crystal Arthritis Network
Affiliations
1
University of Otago, Christchurch, New Zealand; Lisa.Stamp@cdhb.health.nz.
2
University of Otago, Wellington, New Zealand.
PMID:
33004535
DOI:
10.3899/jrheum.200347
No abstract available
Publication types
Letter
MeSH terms
Gout Suppressants / therapeutic use
Gout* / drug therapy
Humans
Hyperuricemia* / drug therapy
Physicians*
Uric Acid
Substances
Gout Suppressants
Uric Acid